Rodríguez-Pérez, Víctor

Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study. [electronic resource] - Progress in neuro-psychopharmacology & biological psychiatry Oct 2002 - 1055-62 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0278-5846

10.1016/s0278-5846(02)00222-1 doi


Antipsychotic Agents--adverse effects
Basal Ganglia Diseases--chemically induced
Benzodiazepines
Body Weight--drug effects
Chronic Disease
Drug Resistance
Female
Follow-Up Studies
Humans
Male
Middle Aged
Olanzapine
Pirenzepine--adverse effects
Psychiatric Status Rating Scales
Schizophrenia--drug therapy